Skip to main content
European Commission logo print header

Article Category

Content archived on 2023-04-13

Article available in the following languages:

EN

Cerebrospinal Upregulation of Endogenous Neurotrophics Part 2

The Second Part of the Previous BDNF Enhancement Theory: Cerebrospinal Upregulation for systemic Relief of Neural Ailments.

Health icon Health

Object of the Invention In order to eliminate the disadvantages of the state of the art, an object of the invention is to treat the neuroendocrinal damage caused by the autoimmune diseases. Another object of the invention is to increase the NGF expression, thereby supporting the production of new nerve cells. Another object of the invention is to support the axone regeneration rate and the presynaptic neurotransmission. Another object of the invention is to suppress IL-4, IL-6 and tnf-alpha. Another object of the invention is to stimulate the repair of the muscle and connective tissue. Another object of the invention is to promote the production of testosterone. In order to achieve the aforesaid advantages, the invention is a composition for treating the neuroendocrinal damage caused by the autoimmune diseases, said composition being obtained by the components selected from the group comprising dimethyldioscin, 98-e, eurycoma longifolia extract, cissus extract that are used individually or in combinations. The structural and characteristic features and all the advantages of the invention will become more clearly understood from the detailed description provided below and therefore, the evaluation must be made taking this detailed description into consideration. Detailed Description of the Invention The invention is a composition comprising dioscin derivatives and 98-E, eurycoma longifolia and cissus extracts for treating the neuroendocrinal damage caused by the autoimmune diseases. Dimethyl dioscin and 98-E, ingredients of the invention, increase the NGF expression, thereby supporting the production of new nerve cells. Dimethyldioscin and 98-E also support the axone regeneration rate and the presynaptic neurotransmission. Eurycoma longifolia extract (100:1) and Cissus extract (5:1, 10:1), other ingredients of the invention, suppress immunoglobulin E, IL-4, IL-6 and tnf-alpha. Eurycoma longifolia extract (100:1) and Cissus extract also stimulate the repair of the muscle and connective tissue. Eurycoma longifolia extract (100:1) and Cissus extract also promote the production of testosterone. The composition according to the invention contains dimethyldioscin, 98-e, eurycoma longifolia extract (100:1), cissus extract (5:1), (10:1). Said formulation is obtained by a mixture of the aforesaid components according to the following ratios by weight: 13-28% dimethyldioscin, 17-44% 98-e, 50-18% eurycoma longifolia extract (100:1), 20-10% cissus extract (5:1), (10:1). The composition is obtained from the aforesaid components selected from the aforesaid group and used according to the mentioned weight ratio ranges individually or in combinations. Said invention also encompasses the use of said composition for treating the neuroendocrinal damage caused by the autoimmune diseases and the manufacture thereof for this purpose. CLAIMS 1. A composition for treating the neuroendocrinal damage caused by the autoimmune diseases, said composition being obtained by the components selected from the group comprising dimethyldioscin, 98-e, eurycoma longifolia extract, cissus extract that are used individually or in combinations. 2. A composition according to Claim 1 characterized in that it comprises 13-28% by weight dimethyldioscin. 3. A composition according to Claim 1 characterized in that it comprises 17-44% by weight 98-e. 4. A composition according to Claim 1 characterized in that it comprises 50-18% by weight eurycoma longifolia extract (100:1). 5. A composition according to Claim 1 characterized in that it comprises 20-10% by weight cissus extract (5:1). 6. A composition according to Claim 1 characterized in that it comprises 20-10% by weight cissus extract (10:1). 7. Use of the components obtained individually or in combinations from the group consisting of dimethyldioscin, 98-e, eurycoma longifolia extract, cissus extract are a potential candidate for above mentioned ailments.